Buspirone enhances immobility in the forced swim test in mice

Yoshihisa Kitamura, Tadashi Nagatani

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We studied the effects of buspirone and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on duration of immobility in mice in the forced swim test. Buspirone [3-10 mg/kg, intraperitoneally (IP)] potently and dose dependently increased the duration of immobility in mice. In contrast, following a single dose of 8-OH-DPAT (1-3 mg/kg, IP), there was a dose-dependent decrease in the duration of immobility. Pretreatment with the 5-HT synthesis inhibitor p-chlorophenylalanine (200 mg/kg, IP, 3 days before further drug treatment) did not alter the effects of buspirone or 8-OH-DPAT The increase in the duration of immobility induced by buspirone (3 mg/kg, IP) was blocked by NAN-190 [1-(2-methoxyphenyl)-4-(4-[2-phthalimido]butyl)-piperazine hydrobromide, 1 mg/kg, IP), a postsynaptic 5-HT(1A) receptor antagonist. However, the effect of 8-OH-DPAT (1 mg/kg, IP) was not blocked by NAN-190 (1 mg/kg, IP). The effect of buspirone (3 mg/kg, IP) was blocked by apomorphine (0.3 mg/kg, IP), a dopamine receptor agonist. Based on the results of this study, it is suggested that the effects of buspirone and of 8-OH-DPAT on immobility in the forced swim test may occur through different mechanisms.

Original languageEnglish
Pages (from-to)445-451
Number of pages7
JournalPharmacology Biochemistry and Behavior
Volume55
Issue number3
DOIs
Publication statusPublished - Nov 1996
Externally publishedYes

Fingerprint

Buspirone
8-Hydroxy-2-(di-n-propylamino)tetralin
Fenclonine
Drug therapy
Receptor, Serotonin, 5-HT1A
Apomorphine
Dopamine Agonists
Serotonin
hydroxide ion
Pharmaceutical Preparations

Keywords

  • 5-Hydroxytryptamine (5-HT)(1A) receptor
  • 8-OH-DPAT
  • Buspirone
  • Forced swim test

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Buspirone enhances immobility in the forced swim test in mice. / Kitamura, Yoshihisa; Nagatani, Tadashi.

In: Pharmacology Biochemistry and Behavior, Vol. 55, No. 3, 11.1996, p. 445-451.

Research output: Contribution to journalArticle

@article{50c12ebf81ac464ba3d9bce8628e1ec4,
title = "Buspirone enhances immobility in the forced swim test in mice",
abstract = "We studied the effects of buspirone and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on duration of immobility in mice in the forced swim test. Buspirone [3-10 mg/kg, intraperitoneally (IP)] potently and dose dependently increased the duration of immobility in mice. In contrast, following a single dose of 8-OH-DPAT (1-3 mg/kg, IP), there was a dose-dependent decrease in the duration of immobility. Pretreatment with the 5-HT synthesis inhibitor p-chlorophenylalanine (200 mg/kg, IP, 3 days before further drug treatment) did not alter the effects of buspirone or 8-OH-DPAT The increase in the duration of immobility induced by buspirone (3 mg/kg, IP) was blocked by NAN-190 [1-(2-methoxyphenyl)-4-(4-[2-phthalimido]butyl)-piperazine hydrobromide, 1 mg/kg, IP), a postsynaptic 5-HT(1A) receptor antagonist. However, the effect of 8-OH-DPAT (1 mg/kg, IP) was not blocked by NAN-190 (1 mg/kg, IP). The effect of buspirone (3 mg/kg, IP) was blocked by apomorphine (0.3 mg/kg, IP), a dopamine receptor agonist. Based on the results of this study, it is suggested that the effects of buspirone and of 8-OH-DPAT on immobility in the forced swim test may occur through different mechanisms.",
keywords = "5-Hydroxytryptamine (5-HT)(1A) receptor, 8-OH-DPAT, Buspirone, Forced swim test",
author = "Yoshihisa Kitamura and Tadashi Nagatani",
year = "1996",
month = "11",
doi = "10.1016/S0091-3057(96)00116-5",
language = "English",
volume = "55",
pages = "445--451",
journal = "Pharmacology, Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Buspirone enhances immobility in the forced swim test in mice

AU - Kitamura, Yoshihisa

AU - Nagatani, Tadashi

PY - 1996/11

Y1 - 1996/11

N2 - We studied the effects of buspirone and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on duration of immobility in mice in the forced swim test. Buspirone [3-10 mg/kg, intraperitoneally (IP)] potently and dose dependently increased the duration of immobility in mice. In contrast, following a single dose of 8-OH-DPAT (1-3 mg/kg, IP), there was a dose-dependent decrease in the duration of immobility. Pretreatment with the 5-HT synthesis inhibitor p-chlorophenylalanine (200 mg/kg, IP, 3 days before further drug treatment) did not alter the effects of buspirone or 8-OH-DPAT The increase in the duration of immobility induced by buspirone (3 mg/kg, IP) was blocked by NAN-190 [1-(2-methoxyphenyl)-4-(4-[2-phthalimido]butyl)-piperazine hydrobromide, 1 mg/kg, IP), a postsynaptic 5-HT(1A) receptor antagonist. However, the effect of 8-OH-DPAT (1 mg/kg, IP) was not blocked by NAN-190 (1 mg/kg, IP). The effect of buspirone (3 mg/kg, IP) was blocked by apomorphine (0.3 mg/kg, IP), a dopamine receptor agonist. Based on the results of this study, it is suggested that the effects of buspirone and of 8-OH-DPAT on immobility in the forced swim test may occur through different mechanisms.

AB - We studied the effects of buspirone and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on duration of immobility in mice in the forced swim test. Buspirone [3-10 mg/kg, intraperitoneally (IP)] potently and dose dependently increased the duration of immobility in mice. In contrast, following a single dose of 8-OH-DPAT (1-3 mg/kg, IP), there was a dose-dependent decrease in the duration of immobility. Pretreatment with the 5-HT synthesis inhibitor p-chlorophenylalanine (200 mg/kg, IP, 3 days before further drug treatment) did not alter the effects of buspirone or 8-OH-DPAT The increase in the duration of immobility induced by buspirone (3 mg/kg, IP) was blocked by NAN-190 [1-(2-methoxyphenyl)-4-(4-[2-phthalimido]butyl)-piperazine hydrobromide, 1 mg/kg, IP), a postsynaptic 5-HT(1A) receptor antagonist. However, the effect of 8-OH-DPAT (1 mg/kg, IP) was not blocked by NAN-190 (1 mg/kg, IP). The effect of buspirone (3 mg/kg, IP) was blocked by apomorphine (0.3 mg/kg, IP), a dopamine receptor agonist. Based on the results of this study, it is suggested that the effects of buspirone and of 8-OH-DPAT on immobility in the forced swim test may occur through different mechanisms.

KW - 5-Hydroxytryptamine (5-HT)(1A) receptor

KW - 8-OH-DPAT

KW - Buspirone

KW - Forced swim test

UR - http://www.scopus.com/inward/record.url?scp=0030296810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030296810&partnerID=8YFLogxK

U2 - 10.1016/S0091-3057(96)00116-5

DO - 10.1016/S0091-3057(96)00116-5

M3 - Article

VL - 55

SP - 445

EP - 451

JO - Pharmacology, Biochemistry and Behavior

JF - Pharmacology, Biochemistry and Behavior

SN - 0091-3057

IS - 3

ER -